Abstract:ABSTRACT A double-blind randomized phase I trial was conducted in human immunodeficiency virus type 1 (HIV-1)-negative subjects receiving vaccines vectored by plasmid DNA and modified vaccinia virus Ankara (MVA) expressing HIV-1 p24/p17 gag linked to a string of CD8+ T-cell epitopes. The trial had two groups. One group received either two doses of MVA.HIVA (2× MVA.HIVA) (n = 8) or two doses of placebo (2× placebo) (n = 4). The second group received 2× pTHr.HIVA followed by one dose of MVA.HIVA (n = 8) or 3× placebo (n = 4). In the pTHr.HIVA-MVA.HIVA group, HIV-1-specific T-cell responses peaked 1 week after MVA.HIVA vaccination in both ex vivo gamma interferon (IFN-γ) ELISPOT (group mean, 210 spot-forming cells/106 cells) and proliferation (group mean stimulation index, 37), with assays detecting positive responses in four out of eight and five out of eight subjects, respectively. No HIV-1-specific T-cell responses were detected in either assay in the 2× MVA.HIVA group or subjects receiving placebo. Using a highly sensitive and reproducible cultured IFN-γ ELISPOT assay, positive responses mainly mediated by CD4+ T cells were detected in eight out of eight vaccinees in the pTHr.HIVA-MVA.HIVA group and four out of eight vaccinees in the 2× MVA.HIVA group. Importantly, no false-positive responses were detected in the eight subjects receiving placebo. Of the 12 responders, 11 developed responses to previously identified immunodominant CD4+ T-cell epitopes, with 6 volunteers having responses to more than one epitope. Five out of 12 responders also developed CD8+ T-cell responses to the epitope string. Induced T cells produced a variety of anti-viral cytokines, including tumor necrosis factor alpha and macrophage inflammatory protein 1β. These data demonstrate that prime-boost vaccination with recombinant DNA and MVA vectors can induce multifunctional HIV-1-specific T cells in the majority of vaccinees.

Electrochemical CO 2 reduction on Single-Atom aluminum catalysts supported on graphene and N-doped Graphene: Mechanistic insights and hydration effects

Enhanced CH4 Production from CO2 Hydrogenation on Γ-Alooh-supported Cobalt Catalyst with Abundant Surface Coordination Unsaturated Oxygen Atoms

Electrochemical CO2 Reduction Reaction on 3d Transition Metal Single-Atom Catalysts Supported on Graphdiyne: A DFT Study

Electrocatalytic Carbon Dioxide Reduction on Graphene-supported Ni Cluster and its Hydride: Insight from First-Principles Calculations

Second generation lithotripsy: an experience of 200 patients.

Understanding the role of central metal and coordination environment of single atom catalysts embedded in graphene flakes on CO2RR performance

Three-Dimensional Nitrogen-Doped Graphene Aerogel-Supported MnO Nanoparticles As Efficient Electrocatalysts for CO2 Reduction to CO

Graphene with SiN3 ligand for superior CO 2 electrochemical reduction

Molecular-Scale Insights into Electrochemical Reduction of CO 2 on Hydrophobically Modified Cu Surfaces

Atomic alkali metal anchoring on graphdiyne as single-atom catalysts for capture and conversion of CO2 to HCOOH

P-Block Aluminum Single-Atom Catalyst for Electrocatalytic CO 2 Reduction with High Intrinsic Activity

Electrocatalytic nitrogen reduction on defective graphene modulated from single atom catalyst to aluminium clusters

A Graphene-Supported Single-Atom FeN 5 Catalytic Site for Efficient Electrochemical CO 2 Reduction.

Catalytic mechanism of sulfur-nitrogen doping metal single-atom graphene-based catalysts for the conversion of CO2 to CH4: a computational study

Theoretical investigation of CO2 electroreduction on N (B)-doped graphdiyne mononlayer supported single copper atom

CO2 Electroreduction Performance of Transition Metal Dimers Supported on Graphene: A Theoretical Study

Discovering a Single‐Atom Catalyst for CO2 Electroreduction to C1 Hydrocarbons: Thermodynamics and Kinetics on Aluminum‐Doped Copper

Performance of a nanowire-like aluminium-based organometallic complex with high activity for the electrocatalysis of CO 2 to CO

Tobacco dependence: a chronic disease.

CO 2 reduction performance of Cu/Er supported on N-doped graphene: A first principles study

Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA- and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV-1 Gag Coupled to CD8+ T-Cell Epitopes